Biotechnology Archives - InvestorWire (IW)

Friday May 14, 2021 - 2:42 pm

Noble Capital Markets and Channelchek to Host Investor Forum C-Suite Interviews During Prestigious 16th Annual World Stem Cell Summit

BOCA RATON, Fla., May 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Noble Capital Markets (“Noble”), a research-driven investment bank, today announces its platinum-level sponsorship of, and collaboration with, the 16th World Stem Cell Summit, to be held virtually June 14-18, 2021. Noble will also provide significant content through its small and microcap investor portal, Channelchek.com. Produced by the nonprofit Regenerative Medicine Foundation (RMF), the 2021 Summit…

Monday Apr 19, 2021 - 8:30 am

Brain Scientific Files Its Annual Report on Form 10-K Announcing 2020 Results

NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF) (the “Company” or “Brain Scientific”), a neurology-focused medical device and software company, filed its Annual Report on Form 10-K for the fiscal year ended Dec. 31, 2020, with the U.S. Securities and Exchange Commission (SEC). Brain Scientific is a neurodiagnostic and predictive technology platform company seeking to provide a…

Wednesday Apr 14, 2021 - 10:00 am

InnerScope Hearing Technologies (OTC: INND) Featured in a 12-Part Series of NASDAQ Produced Interviews on NEWSMAX, Fox Business, and Bloomberg TV Broadcasts

InnerScope's CEO will be featured in a 12-Part series of interviews on NEWSMAX Television "New To The Street" syndicated television show which airs on Sundays at 10 AM EST, and broadcasts across three major US Television Networks to over 540 million homes in the US and international markets ROSEVILLE, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging…

Monday Apr 12, 2021 - 9:35 am

InvestorBrandNetwork (IBN) and BioMedWire (BMW) Announce Collaboration with Dynamic Global Events (DGE) to Serve as Official Media Partners for Upcoming 2021 Events

LOS ANGELES, April 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting companies to the investment community through 50+ brands, today announced it will partner with Dynamic Global Events (“DGE”) as an official media partner for upcoming events in 2021. BioMedWire (“BMW”), a specialized communications platform for the life sciences sector and one of the 50+ brands part of the InvestorBrandNetwork, is also joining…

Wednesday Mar 31, 2021 - 8:30 am

Brain Scientific Starts Selling Its NeuroCaps™ to VA Hospitals

NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF) (the “Company”), a neurology focused medical device and software company, has announced it has received its first purchase order for its NeuroCap™, a pre-gelled, disposable EEG headset, from the Department of Veterans Affairs – VA Medical Centers for one of its hospitals. “Our team at Brain Scientific is proud to start what…

Wednesday Mar 31, 2021 - 8:30 am

Outlier Biopharma to Open One of the Largest Extraction Plants in the Caribbean

KINGSTON, Jamaica, March 31, 2021 (GLOBE NEWSWIRE) -- via InvestorWire - Outlier Biopharma, one of Jamaica’s newest cannabis agro-processing, research, development, manufacturing and distribution companies, is making waves within the local and international cannabis industries with the upcoming opening of its state-of-the-art extraction plant which will be one of the largest of its kind in the Caribbean. The plant, which is scheduled to commence operations…

Tuesday Mar 30, 2021 - 9:30 am

BRS Receives 510(k) Clearance from the US Food and Drug Administration for Surgical Masks

RICHMOND, VA., March 30, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Blackbriar Regulatory Services, LLC (BRS), a firm specializing in helping small to mid-sized domestic and international companies navigate the regulatory landscape to bring their U.S. Food and Drug Administration (FDA) regulated product concepts to market, has recently received FDA 510(k) clearance for its surgical three- and four-ply masks. The 510(k) certification grants BRS the…

Monday Mar 29, 2021 - 8:30 am

XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test

VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of…

Monday Mar 29, 2021 - 8:17 am

InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast Featuring United Medical Equipment Business Solutions Network Inc. President Jason Pratt and VP of Sales Brian Gartland

LOS ANGELES, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s…

Friday Mar 26, 2021 - 8:30 am

180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics

NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF) announces the availability of a broadcast titled, “Controlling Inflammation to Stop Disease.” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To view the full editorial, please visit: https://nnw.fm/VFpw9 Ongoing research and clinical trials for anti-tumor necrosis factor (anti-TNF) antibodies in autoimmune inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ulcerative…

Thursday Mar 25, 2021 - 8:30 am

180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters

NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — 180 Life Sciences Corp. (NASDAQ: ATNF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Controlling Inflammation to Stop Disease,” please visit: https://nnw.fm/VFpw9 Inflammation has been directly linked to a wide variety of physical and…

Wednesday Mar 17, 2021 - 8:30 am

Healthtech Solutions, Inc. (HLTT), Parent Company of Cutting-Edge Medical Technology Companies, Files Reg A With SEC

March 8, 2021, filing to raise up to $75 million. Maximum of 1,500,000 shares of Series B preferred stock offered at price of $50 per share.Healthtech Solutions, Inc. is organized to pursue innovation in the field of medical technology. NEW YORK, March 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (the “Company”), parent company of Medi-Scan, Inc. and RevHeart, Inc., filed a Reg…

Tuesday Mar 16, 2021 - 8:30 am

Brain Scientific Announces Collaboration with JelikaLite in New Clinical Trial

The two neurology device companies will join forces in a clinical trial seeking to reduce the symptoms of autism in children NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announces a collaboration with JelikaLite, a company developing Cognilum™, a non-invasive wearable photobiomodulation device that is being developed to increase the well-being of children…

Tuesday Mar 16, 2021 - 8:30 am

Healthtech Solutions, Inc. (HLTT), Parent Company of Medi-Scan Inc., Announces Incorporation of a New Subsidiary Called RevHeart, Inc.

New subsidiary will further the Company’s research into treating COVID-related heart muscle injury. A patent has been filed for a therapy to ameliorate and potentially repair myocardial damage. NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Healthtech Solutions, Inc. (OTC: HLTT) (the “Company”), parent company of Medi-Scan, Inc., today announces the incorporation of a new subsidiary called RevHeart, Inc. The new subsidiary will conduct further…

Tuesday Mar 16, 2021 - 8:05 am

IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS

VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (“Lighthouse”). Prior to Imagin’s selection of Lighthouse as its contract manufacturer for the i/Blue Imaging System™ in October 2020, the Company received multiple fully functional…

Friday Mar 12, 2021 - 8:30 am

Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset

NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc.(OTCQB: BRSF) today announces it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Brain Scientific’s receipt of U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its next-generation…

Friday Mar 12, 2021 - 8:17 am

InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.

LOS ANGELES, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s…

Tuesday Mar 09, 2021 - 8:30 am

Brain Scientific Announces FDA Clearance for Next-Gen NeuroCap™ EEG Headset

NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announced today it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its next generation NeuroCap™ device. NeuroCap™ is an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where recording of STAT EEGs is desired. “We…

Thursday Feb 18, 2021 - 9:35 am

Clinical Document World Set to Showcase the Latest Innovations and Developments Within the Field of Clinical Documentation Process

NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via BioMedWire -- Lincoln Health Network, a renowned conference production company dedicated to showcasing the latest technologies and trends within the pharmaceutical, medical devices and biotech fields, will be hosting the upcoming Clinical Document World conference in an entirely digital format on February 24-26, 2021. Designed to operate as a one-stop learning experience for life sciences professionals seeking to…

Wednesday Feb 17, 2021 - 9:35 am

Medical Writing Landscape Advancement Summit Provides Unique Learning Opportunities to Improve Content Optimization

NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via BioMedWire -- Lincoln Health Network, a leading conference production company focused on being the go-to source for thought leadership within the fields of pharmaceutical, medical devices and life sciences, will be hosting the second annual Medical Writing Landscape Advancement Summit in an entirely digital format on March 3-4, 2021. Designed to help medical practitioners improve on their medical…

Wednesday Jan 20, 2021 - 10:05 am

InvestorBrandNetwork (IBN) Announces Expanded Collaboration with GSMI to Serve as Official Media Sponsor for All 2021 Events

Additionally, BioMedWire will serve as the official newswire for FWD Pharma, Clinical Document World Virtual, Medical Writing Forum, Strategic HCP Partnerships, Trial Impact Summit and Real World Evidence Summit. NetworkNewsWire will serve as the official newswire of all other GSMI events. NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, today announces that it will expand…

Wednesday Jan 13, 2021 - 8:30 am

Imagin Medical Builds Momentum for 2021

VANCOUVER, British Columbia, and BOSTON, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones met in the second half of 2020 will support the Company in achieving its 2021 goals. Like most companies during 2020, Imagin had to adapt to the unexpected circumstances surrounding COVID-19. The Company implemented emergency measures to…

Wednesday Jan 13, 2021 - 8:30 am

InvestorBrandNetwork (IBN) Coverage Initiated for Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)

NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announces it has selected the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. Imagin Medical’s first product is the…

Wednesday Jan 13, 2021 - 8:30 am

InvestorBrandNetwork Announces C3 Chat Show Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco

LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that John Climaco, Chairman and CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP), was recently interviewed on the C3 Chat Show Podcast, a series that addresses topics related to entrepreneurship, life experiences and best practices from experts. The podcast, co-hosted by Sid Vaidya and…

Monday Dec 28, 2020 - 8:00 am

CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application

HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to…

Monday Dec 28, 2020 - 6:30 am

CB Scientific, Inc. (CBSC), Distributor Mango Wellness and My Cardia Thailand Well Positioned for Growth in 2021

Introductory exhibits at Royal College of Physicians of Thailand and Thailand Cardiologist Annual Conference result in dozens of product trials and new hospital contracts ESCONDIDO, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, announces today the addition of dozens of new…

Monday Dec 21, 2020 - 8:30 am

CannAssist International Xceptol Brand Approved and Included by RangeMe — Increasing SKUs and Providing Access to Over 10,000 Retailers

NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CannAssist International Corp. (OTCQB: CNSC) ("CannAssist International" or the "Company") today announces its Xceptol brand approval on the distribution website RangeMe. This week, RangeMe added Xceptol drops and capsules to the Xceptol pain cream products already available on the RangeMe platform, bringing the number of available Xceptol SKUs on the platform to 10, with additional SKUs coming in the…

Thursday Dec 17, 2020 - 8:30 am

Brain Scientific To Enter the U.S. Pediatric Market with NeuroCap™ for Children

The New Product Offering will Bring Advanced, Disposable EEG Technology to Pediatric Clinicians across the Country NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has announced its next generation disposable EEG cap, NeuroCap™, will now be available to the pediatric market across the U.S. The product launch allows Brain Scientific to bring faster,…

Wednesday Dec 16, 2020 - 8:30 am

InvestorBrandNetwork Announces ‘Want Money Got Money’ Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco

LOS ANGELES, Dec. 16, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that John Climaco, chairman and CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP), recently appeared on the “Want Money Got Money” podcast, a series that helps entrepreneurs learn from the stories, secrets and skills of the world’s most brilliant and interesting startup founders and…

Tuesday Dec 15, 2020 - 8:30 am

Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering

Widening Its Investor Network Will Allow Brain Scientific to Continue Its Work in Creating Advanced Technology Devices and Software for the Neurology Market NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it has launched a Regulation A+ equity crowdfunding campaign following the qualification of its Form 1-A offering circular by the…

Wednesday Dec 09, 2020 - 9:00 am

InvestorBrandNetwork Announces Gamechangers LIVE Interview with CNS Pharmaceuticals Inc. Chairman & CEO John Climaco

LOS ANGELES, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that John Climaco, Chairman & CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP), recently appeared on Gamechangers LIVE, a podcast series putting a spotlight on individuals who are gamechangers in their fields and sharing perspective on their journeys, mindsets, struggles and successes in…

Friday Dec 04, 2020 - 8:30 am

Brain Scientific to Showcase Disposable EEG Headset NeuroCap(TM) at American Epilepsy Society Annual Meeting

NEW YORK, Dec. 04, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it will participate in AES2020 – the all-new virtual event for epilepsy professionals in academia, clinical practice, industry and advocacy, on Dec. 4–8, 2020. The American Epilepsy Society's Annual Meeting is the largest meeting and exhibition in the world to share common scientific…

Wednesday Dec 02, 2020 - 8:30 am

Brain Scientific Files Patent Application For New Long-Term Monitoring EEG Cap

NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has filed a provisional patent application in the United States Patent and Trademark Office (“USPTO”) entitled, “FULL HEAD APPARATUS AND ELECTRODES FOR CONDUCTING ELECTROENCEPHALOGRAPHY.” During EEG testing electrodes are put to the person’s head by either a cap application or placement of each electrode. The latter…

Tuesday Nov 24, 2020 - 8:17 am

InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein

LOS ANGELES, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of the Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Stock2Me Podcasts feature a fascinating array of companies and individuals, many of whom are actively revolutionizing…

Tuesday Nov 24, 2020 - 8:00 am

CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy

HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to…

Tuesday Nov 17, 2020 - 9:00 am

Brain Scientific Aims to Expand into the EU Market, Retains Registration Firm in Europe

NEW YORK, Nov. 17, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has entered into an agreement with Europe’s leading certification and compliance company AFINA s.r.o. The agreement specifies that AFINA will act as an authorized representative for Brain Scientific in the European Union and assist with registering Brain Scientific’s advanced EEG solutions in 32 countries in the European market.…

Thursday Nov 12, 2020 - 5:02 pm

Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update

Highlights include closing $19.2 million public offering, uplisting to Nasdaq, and positive progress with multiple candidates currently in Processa’s clinical drug pipeline HANOVER, MD., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of drug products that are intended to provide treatment for and improve the survival and/or quality of…

Thursday Nov 12, 2020 - 7:30 am

CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC

Acquisition will expand Ambulatory Remote Cardiac ECG Monitoring product technology offering and outreach into US and international markets ESCONDIDO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, is pleased to announce a definitive purchase agreement to acquire Datrix, LLC (Datrix), a…

Tuesday Nov 03, 2020 - 9:20 am

Processa Pharmaceuticals Schedules Conference Call to Discuss Third Quarter Results and Provide Drug Development Update on Nov. 12 at 5:30 p.m. ET

HANOVER, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients who have high unmet medical need conditions, today announces it will host a conference call and live webcast on Nov. 12, 2020, at 5:30 p.m. Eastern time to discuss its…

Press Releases

Press Release Category: Biotechnology

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions